Skip to main content
Top
Published in: Reproductive Health 1/2009

Open Access 01-12-2009 | Research

Audit of short term outcomes of surgical and medical second trimester termination of pregnancy

Authors: Annamarie Mauelshagen, Lynn C Sadler, Helen Roberts, Mahesh Harilall, Cynthia M Farquhar

Published in: Reproductive Health | Issue 1/2009

Login to get access

Abstract

Background

As comparisons of modern medical and surgical second trimester termination of pregnancy (TOP) are limited, and the optimum method of termination is still debated, an audit of second trimester TOP was undertaken, with the objective of comparing the outcomes of modern medical and surgical methods.

Methods

All cases of medical and surgical TOP between the gestations of 13 and 20 weeks from 1st January 2007 to 30th June 2008, among women residing in the local health board district, a tertiary teaching hospital in an urban setting, were identified by a search of ICD-10 procedure codes (surgical terminations) and from a ward database (medical terminations). Retrospective review of case notes was undertaken. A total of 184 cases, 51 medical and 133 surgical TOP, were identified. Frequency data were compared using Chi-squared or Fischer's Exact tests as appropriate and continuous data are presented as mean and standard deviation if normally distributed or median and interquartile range if non-parametric.

Results

Eighty-one percent of surgical terminations occurred between 13 to 16 weeks gestation, while 74% of medical terminations were performed between 17 to 20 weeks gestation. The earlier surgical TOP occurred in younger women and were more often indicated for maternal mental health. Sixteen percent of medical TOP required surgical delivery of the placenta. Evacuation of retained products was required more often after medical TOP (10%) than after surgical TOP (1%). Other serious complications were rare.

Conclusion

Both medical and surgical TOP are safe and effective for second trimester termination. Medical TOP tend to be performed at later gestations and are associated with a greater likelihood of manual removal of the placenta and delayed return to theatre for retained products. This case series does not address long term complications.
Literature
1.
go back to reference Sedgh G, Henshaw S, Singh S, Åhman E, Shah I: Induced abortion: estimated rates and trends worldwide. The Lancet. 2007, 370 (9595): 1338-1345. 10.1016/S0140-6736(07)61575-X.CrossRef Sedgh G, Henshaw S, Singh S, Åhman E, Shah I: Induced abortion: estimated rates and trends worldwide. The Lancet. 2007, 370 (9595): 1338-1345. 10.1016/S0140-6736(07)61575-X.CrossRef
3.
go back to reference Lohr PA, Hayes JL, Gemzell-Danielsson K: Surgical versus medical methods for second trimester induced abortion (Review). Cochrane Database of Syst Rev. 2008, CD006714-DOI: 10.1002/14651858.CD006714.pub2, 1 Lohr PA, Hayes JL, Gemzell-Danielsson K: Surgical versus medical methods for second trimester induced abortion (Review). Cochrane Database of Syst Rev. 2008, CD006714-DOI: 10.1002/14651858.CD006714.pub2, 1
4.
go back to reference Poon LCY, Parsons J: Audit of the effectiveness of cervical preparation with Dilapan prior to late second-trimester (20-24 weeks) surgical termination of pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 2007, 114 (4): 485-488.CrossRef Poon LCY, Parsons J: Audit of the effectiveness of cervical preparation with Dilapan prior to late second-trimester (20-24 weeks) surgical termination of pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 2007, 114 (4): 485-488.CrossRef
5.
go back to reference Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM: Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004, 69: 51-58. 10.1016/j.contraception.2003.09.006.CrossRefPubMed Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM: Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004, 69: 51-58. 10.1016/j.contraception.2003.09.006.CrossRefPubMed
6.
go back to reference Lalitkumar S, Bygdeman M, Gemzell-Danielson K: Mid-trimester Induced Abortion: a review. Hum Reprod Update. 2007, 13 (1): 37-52. 10.1093/humupd/dml049.CrossRefPubMed Lalitkumar S, Bygdeman M, Gemzell-Danielson K: Mid-trimester Induced Abortion: a review. Hum Reprod Update. 2007, 13 (1): 37-52. 10.1093/humupd/dml049.CrossRefPubMed
7.
go back to reference Gemzell-Danielsson K, Lalitkumar S: Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management. Reprod Health Matters. 2008, 16 (31 Suppl): 162-72. 10.1016/S0968-8080(08)31371-8.CrossRefPubMed Gemzell-Danielsson K, Lalitkumar S: Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management. Reprod Health Matters. 2008, 16 (31 Suppl): 162-72. 10.1016/S0968-8080(08)31371-8.CrossRefPubMed
8.
go back to reference Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S: Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol. 2004, 103: 729-37. 10.1097/01.AOG.0000116260.81570.60.CrossRefPubMed Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S: Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol. 2004, 103: 729-37. 10.1097/01.AOG.0000116260.81570.60.CrossRefPubMed
9.
go back to reference Grimes DA, Smith SM, Witham AD: Mifepristone and misoprostol versus dilatation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology. 2004, 111: 148-53.CrossRef Grimes DA, Smith SM, Witham AD: Mifepristone and misoprostol versus dilatation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology. 2004, 111: 148-53.CrossRef
10.
go back to reference Autry AM, Hayes EC, Jacobson GF, Kirby RS: A comparison of medical induction and dilatation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002, 187: 393-7. 10.1067/mob.2002.123887.CrossRefPubMed Autry AM, Hayes EC, Jacobson GF, Kirby RS: A comparison of medical induction and dilatation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002, 187: 393-7. 10.1067/mob.2002.123887.CrossRefPubMed
11.
go back to reference Goh SE, Thong KJ: Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception. 2007, 73: 516-19. 10.1016/j.contraception.2005.12.004.CrossRef Goh SE, Thong KJ: Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception. 2007, 73: 516-19. 10.1016/j.contraception.2005.12.004.CrossRef
12.
go back to reference Grossman D, Blanchard K, Blumenthal P: Complications after Second Trimester Surgical and Medical Abortion. Reprod Health Matters. 2008, 16 (31 Suppl): 173-82. 10.1016/S0968-8080(08)31379-2.CrossRefPubMed Grossman D, Blanchard K, Blumenthal P: Complications after Second Trimester Surgical and Medical Abortion. Reprod Health Matters. 2008, 16 (31 Suppl): 173-82. 10.1016/S0968-8080(08)31379-2.CrossRefPubMed
14.
go back to reference Medical methods for termination of pregnancy. Report of a WHO Scientific Group. World Health Organization Technical Report Series. 1997, Geneva: World Health Organization, 871: Medical methods for termination of pregnancy. Report of a WHO Scientific Group. World Health Organization Technical Report Series. 1997, Geneva: World Health Organization, 871:
Metadata
Title
Audit of short term outcomes of surgical and medical second trimester termination of pregnancy
Authors
Annamarie Mauelshagen
Lynn C Sadler
Helen Roberts
Mahesh Harilall
Cynthia M Farquhar
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Reproductive Health / Issue 1/2009
Electronic ISSN: 1742-4755
DOI
https://doi.org/10.1186/1742-4755-6-16

Other articles of this Issue 1/2009

Reproductive Health 1/2009 Go to the issue